ReviewBreast (Edinburgh, Scotland)2026

Surgery-first versus neoadjuvant chemotherapy in stage I (cT1c) triple-negative breast cancer: A critical reappraisal.

M Dediu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.